• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach.

作者信息

Kuscu Ozlem Ozkan, Ergenoglu Pinar

机构信息

Baskent University: Baskent Universitesi, Ankara, Turkey.

出版信息

Rom J Anaesth Intensive Care. 2022 Dec 29;28(2):89-90. doi: 10.2478/rjaic-2021-0015. eCollection 2021 Dec.

DOI:10.2478/rjaic-2021-0015
PMID:36844115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9949026/
Abstract
摘要

相似文献

1
Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach.托珠单抗在血小板减少的COVID-19患者中的应用：治疗方法面临的挑战
Rom J Anaesth Intensive Care. 2022 Dec 29;28(2):89-90. doi: 10.2478/rjaic-2021-0015. eCollection 2021 Dec.
2
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.COVID-19 疫苗接种和/或同时 COVID-19 感染可能引发免疫性血栓性血小板减少性紫癜（iTTP）复发。
BMJ Case Rep. 2022 Jul 28;15(7):e247524. doi: 10.1136/bcr-2021-247524.
3
Critical Care COVID-19 Patient with a Picture of Thrombotic Thrombocytopenic Purpura.患有血栓性血小板减少性紫癜症状的重症监护 COVID-19 患者。
Eur J Case Rep Intern Med. 2020 Dec 15;7(12):002143. doi: 10.12890/2020_002143. eCollection 2020.
4
Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).新冠病毒疾病药物治疗最大规模临床试验的当前进展洞察（截至2021年1月）
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2021 Apr 23;42(1):5-18. doi: 10.2478/prilozi-2021-0001.
5
COVID-19 and thrombotic thrombocytopenic purpura: A case report.COVID-19 与血栓性血小板减少性紫癜：一例报告。
J Pak Med Assoc. 2023 Feb;73(2):407-409. doi: 10.47391/JPMA.4992.
6
COVID 19 infection associated with thrombotic thrombocytopenic purpura.COVID-19 感染相关的血栓性血小板减少性紫癜。
J Thromb Thrombolysis. 2021 Aug;52(2):504-507. doi: 10.1007/s11239-021-02452-0. Epub 2021 Apr 27.
7
Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience.长春新碱作为血栓性血小板减少性紫癜治疗性血浆置换的辅助治疗：单中心经验。
Balkan Med J. 2018 Nov 15;35(6):417-421. doi: 10.4274/balkanmedj.2017.1215. Epub 2018 Jul 3.
8
[Acquired thrombotic thrombocytopenic purpura following COVID-19].[新型冠状病毒肺炎后获得性血栓性血小板减少性紫癜]
Rinsho Ketsueki. 2022;63(11):1530-1534. doi: 10.11406/rinketsu.63.1530.
9
Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19.新冠病毒感染后不久接种mRNA-1273新冠疫苗后血栓性血小板减少性紫癜复发
Case Rep Hematol. 2021 Sep 13;2021:4130138. doi: 10.1155/2021/4130138. eCollection 2021.
10
Isolated immune thrombocytopenic purpura in a young adult Covid-19 patient.年轻成人 COVID-19 患者孤立性免疫性血小板减少性紫癜。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10850-10852. doi: 10.26355/eurrev_202010_23447.

本文引用的文献

1
Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study.托珠单抗治疗重症新型冠状病毒肺炎患者：一项回顾性队列研究。
EClinicalMedicine. 2020 Jun 20;24:100418. doi: 10.1016/j.eclinm.2020.100418. eCollection 2020 Jul.
2
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子（包括白细胞介素 6）在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
3
Tocilizumab: therapy and safety management.托珠单抗：治疗与安全管理。
Joint Bone Spine. 2010 Jun;77 Suppl 1:S3-100. doi: 10.1016/S1297-319X(10)70001-4. Epub 2010 Jun 17.
4
Tocilizumab: a review of its use in the management of rheumatoid arthritis.托珠单抗：类风湿关节炎治疗应用综述
Drugs. 2009;69(5):609-32. doi: 10.2165/00003495-200969050-00007.